Ryan J Brisson

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Prognostic Factors

Squamous Cell Carcinoma

Tyrosine Kinase

Top Venues

Health science reports

Journal of neuro-oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Vincent Cassidy, Ryan J Brisson
The ruse of reduction - comment to Zeng et al. Journal of neuro-oncology (2023)
Ryan J Brisson, Thomas J Quinn, Rohan L Deraniyagala
The role of chemotherapy in the management of olfactory neuroblastoma: A 40-year surveillance, epidemiology, and end results registry study. Health science reports 4 (2) (2021)
Sara E Kochanny, Francis P Worden, Douglas R Adkins, Dean W Lim, Julie E Bauman, Stephanie A Wagner, Ryan J Brisson, Theodore G Karrison, Walter M Stadler, Everett E Vokes, Tanguy Y Seiwert
A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma. Cancer 126 (10) (2020)
Tanguy Y Seiwert, Sara E Kochanny, Kevin Wood, Francis P Worden, Douglas R Adkins, James L Wade, Bethany G Sleckman, Daniel Anderson, Ryan J Brisson, Theodore Karrison, Walter M Stadler, Everett E Vokes
A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO study. Cancer 126 (14) (2020)
Ryan J Brisson, Sara Kochanny, Saba Arshad, Allison Dekker, Jonas A DeSouza, Vassiliki Saloura, Everett E Vokes, Tanguy Y Seiwert
A pilot study of the pan-class I PI3K inhibitor buparlisib in combination with cetuximab in patients with recurrent or metastatic head and neck cancer. Head & neck 41 (11) (2019)